Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs

Affiliations

• ¹ The Institute of Cancer Research, London, UK. Johnjones7@nhs.net.
• ² Brighton and Sussex Medical School, Brighton, UK. Johnjones7@nhs.net.
• ³ Kings College Hospital NHS Foundation Trust, London, UK. Johnjones7@nhs.net.
• ⁴ The Institute of Cancer Research, London, UK.
• ⁵ Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany.
• ⁶ Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Arkansas, USA.
• ⁷ Indiana University School of Medicine, Indiana, USA.
• ⁸ The Royal Marsden Hospital, London, UK.
• ⁹ Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
• ¹⁰ Perlmutter Cancer Center, NYU Langone Health, New York, USA.
• ¹¹ Apple Tree Partners, London, UK.
• ¹² The Institute of Cancer Research, London, UK. charlotte.pawlyn@icr.ac.uk.
• ¹³ The Royal Marsden Hospital, London, UK. charlotte.pawlyn@icr.ac.uk.